Mato
ShowsHow it worksAI talentsFree toolsPricing
Book a demo
ShowsHow it worksAI talentsFree toolsPricingSign in
Mato
Mato

The first generation of AI talents. Live AI media for brands, networks and creators.

ElevenLabs GrantsAWS ActivateGoogle for StartupsNVIDIA Inception Program

Product

  • How it works
  • AI talents
  • Documentation
  • The studio
  • Pricing
  • Embed player
  • Mato MCP
  • Mato Voice
  • Voice Studio
  • Changelog

Company

  • About
  • Vision
  • Partners
  • Affiliates
  • Blog
  • CustomersComing soon
  • CareersComing soon
  • Press kit
  • Contact

Resources

  • Investor overview
  • Free podcast tools
  • Free podcast transcription
  • Podcast ROI calculator
  • API docsComing soon
  • SecurityComing soon
  • StatusComing soon

© 2026 Mato. All rights reserved.

English · Multiple languages available

PrivacyTerms

Live Interview

And why does that matter?

This is how a Mato agent talks. Take the other seat: answer a few and feel it follow the thread.

Try it yourself

Podcast charts

Clinical and Experimental Ophthalmology Conversations

Published by RANZCO

  • Medicine
  • Health & fitness

"Clinical and Experimental Ophthalmology Conversations” is the official podcast of Clinical & Experimental Ophthalmology. It provides in-depth, behind-the-scenes interviews with authors of hot topic papers from the journal. Each episode discusses a recently published manuscript, highlighting key findings, clinical impact and how new evidence is shaping ophthalmic practice. Designed for ophthalmologists, orthoptists, optometrists and nurses, the series bridges research with real-world application. “Clinical and Experimental Ophthalmology Conversations” delves into authors’ personal perspectives, areas of debate and insights into the future of the field of ophthalmology. Subscribe and listen to stay at the forefront of innovation in ophthalmology.

Listen on Apple Podcasts, opens in a new tabMake something like it

On the charts

1 chart placement

Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.

  1. Number 39MedicineAustralia

From the feed

Recent episodes

The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.

  1. Episode 4: Transpupillary Thermotherapy (TTT) in Small Uveal Melanoma from Clinical and Experimental Ophthalmology Conversations, opens in a new tab

    Aug 12, 202619 min

    Transpupillary Thermotherapy (TTT) is a globe-salvage local laser treatment that has been used for the treatment of smaller choroidal melanomas. In this retrospective study of 850 patients from Sweden, long-term outcomes including local recurrence and disease-specific survival were found to be worst with TTT alone, followed by combined plaque brachytherapy with TTT, then plaque brachytherapy alone. This raises questions over whether TTT should have any role in the treatment of uveal melanoma and highlights the importance of correct local therapy in reducing long-term mortality from metastases.

  2. Episode 3: Detecting Reticular Pseudodrusen with Artificial Intelligence from Clinical and Experimental Ophthalmology Conversations, opens in a new tab

    Mar 1, 202621 min

    Reticular pseudodrusen (otherwise known as subretinal drusenoid deposits) are an important finding in age-related macular degeneration. They are a risk for geographic atrophy development and growth. In this study, an internally and externally validated deep-learning algorithm was developed to automatically identify reticular pseudodrusen with similar to better accuracy than retinal specialists. This allows for future quantification of reticular pseudodrusen in clinical trials, an important next step to learning more about the importance of this sign.

  3. Episode 2: Tattoo Associated Uveitis - More Common than you Might Realise from Clinical and Experimental Ophthalmology Conversations, opens in a new tab

    Feb 10, 202617 min

    This large case series from Australia reviews 40 patients with tattoo associated uveitis. Most cases were found to be bilateral. Although all forms of uveitis are possible, anterior uveitis is the most common presentation, occurring in 70% of eyes. Vision was commonly affected, such that two-thirds of patients required long term immunosuppression. Given that 25% of the Australian population has a tattoo, asking for this is a critical question in any patient presenting with uveitis.

  4. Episode 1: Dominant Optic Atrophy - in Search of Biomarkers from Clinical and Experimental Ophthalmology Conversations, opens in a new tab

    Dec 1, 202521 min

    A recent systematic review and meta-analysis of studies on dominant optic atrophy found that visual acuity was the only biomarker with longitudinal data, and its rate of change did not differ significantly from zero. These findings highlight a critical gap in the field - robust, sensitive biomarkers capable of capturing disease progression are lacking. Identifying alternative structural, functional or molecular biomarkers will be essential for designing and validating future therapeutic clinical trials in dominant optic atrophy.

Ranking source

Apple Podcasts rankings via the Mato Topic Intelligence Platform.

Observed September 20, 2026.

Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.

Pairs with

What to do with a chart

01ShowsThe shows Mato publishesEvery public Mato show, its episodes, and the Apple placements it holds.02AI talentPick the voice before the formatThe live roster of hosts, each with samples you can listen to before you commit.03How it worksFrom an idea to a published episodeWhat Mato does between the brief and the feed, step by step.

Steal the structure, not the show

Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.

Hear a Mato showCreate a show inspired by this